Bioforce AG, Switzerland acquired the remaining shares in joint venture Bioforce Denmark A/S, Denmark
Zurich – CFI Switzerland is pleased to announce that they supported Bioforce AG, Switzerland in the acquisition of the shares it did not already own in the joint venture with Bioforce Denmark A/S, Denmark. Prior to closing the transaction, Bioforce AG had a minority interest in Bioforce Denmark A/S.
Bioforce AG develops and produces phytopharmaceuticals, nutraceuticals and food supplements for international distribution. Besides its products, the philosophy of Bioforce is to focus on comprehensive and well-founded information on health topics. Bioforce has 350 employees and generates sales of approx. CHF 110 m.
Bioforce Denmark A/S is the exclusive distributor of Bioforce products in Denmark. The company is run by the founder and owner.
The parties agreed not to disclose further transaction details.
The transaction closed on 1 January 2019.
Healthcare & Life Sciences
acquired the shares it did not already own in its Danish distributor
Transaction details
Bioforce AG (Switzerland), which develops and produces phytopharmaceuticals, nutraceuticals and food supplements, acquired the shares it did not already own in the joint venture with Bioforce Denmark A/S (Denmark), which is the exclusive distributor of Bioforce products
This transaction was advised by:
Malte Jantz
Partner, Managing DirectorOur latest transactions
Business Services
has acquired the business unit of
Transaction details
Contisystems, a Portuguese provider of end-to-end personalised customer communications products, has acquired the business unit of Real Panóplia, a local customer communications specialist